Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ANY Sphere 3D Corp. Common Shares
$2.42 -3.20% -0.08
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ANY stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 21.8M
Enterprise value 23.0M
Trailing PE -0.32835820895522
Forward PE -0.78125
PEG Ratio 0.0052017142012709
Enterprise to EBITDA -3.33
Enterprise to revenue 2.372
Price to book MRQ 1.3455328
Price to sales TTM 2.2402759

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 9.7M
EBITDA 3.4M
Diluted EPS TTM -10.11
Total Cash (MRQ) 2.8M
Current ratio (MRQ) 1.034
Operating Cash Flow (TTM) -15213000

ANY trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ANY News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.